Marx FM

Sputum availability and quality in country-level TB prevalence surveys
Papadopoulou P, Gaeddert M, Gupta-Wright A, Denkinger CM, Marx FM

International Union Against Tuberculosis and Lung Disease

(2024)

https://doi.org/10.5588/ijtldopen.24.0117
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research
Broger T, Marx FM, Theron G, Marais B, Nicol M, Kerkhoff A, Nathavitharana R, Huerga H, Gupta-Wright A, Kohli M, Nichols B, Muyoyeta M, Meintjes G, Ruhwald M, Peeling R, Pai N, Pollock N, Pai M, Cattamanchi A, Dowdy D, Dewan P, Denkinger C

The Lancet Global Health

(2024)

https://doi.org/10.1016/S2214-109X(24)00148-7
Impact of interventions for tuberculosis prevention and care in South Africa – a systematic review of mathematical modelling studies
Brown LR, van Schalkwyk C, de Villiers AK, Marx FM

South African Medical Journal

(2023)

https://doi.org/10.7196/SAMJ.2023.v113i3.16812
A systematic review of risk factors for mortality among tuberculosis patients in South Africa
Nicholson TJ, Hoddinott G, Seddon JA, Claassens MM, van der Zalm MM, Lopez E, Bock P, Caldwell J, Da Costa D, de Vaal C, Dunbar R, Du Preez K, Hesseling AC, Joseph K, Kriel E, Loveday M, Marx FM, Meehan SA, Purchase S, Naidoo K, Naidoo L, Solomon-Da Costa F, Sloot R, Osman M

Systematic Reviews

(2023)

https://doi.org/10.1186/s13643-023-02175-8
Breathing back better! A state of the art on the benefits of functional evaluation and rehabilitation of post-tuberculosis and post-COVID lungs.
Pontali E, Silva DR, Marx FM, Caminero JA, Centis R, Muhwa JC, Tiberi S, Migliori GB

Archivos de Bronconeumología

(2022)

https://doi.org/10.1016/j.arbres.2022.05.010
Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence?
Moore DP, Hesseling AC, Marx FM

Clinical Infectious Diseases

(2022)

https://doi.org/10.1016/j.cmi.2022.01.013
Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care
Marx FM, Meehan SA, Jivan D, Dunbar R, Hoddinott G, Hesseling AC, Osman M

The International Journal of Tuberculosis and Lung Disease

(2022)

https://doi.org/10.5588/ijtld.21.0332
Spatially targeted digital chest radiography to reduce tuberculosis in high-burden settings: a study of adaptive decision making
de Villiers AK, Dye D, Yaesoubi R, Cohen T, Marx FM

Epidemics

(2022)

https://doi.org/10.1016/j.epidem.2022.100540
Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis
Marx FM, Hauer B, Menzies NA, Haas W, Perumal N

BMC Public Health

(2021)

https://doi.org/10.1186/s12889-021-12142-4
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, Allwood BW, Byrne AL, Mortimer K, Wallis RS, Fox GJ, Leung CC, Chakaya JM, Seaworth B, Rachow A, Marais BJ, Furin J, Akkerman OW, Al Yaquobi F, Amaral AFS, Borisov S, Caminero JA, Carvalho ACC, Chesov D, Codecasa LR, Teixeira RC, Dalcolmo MP, Datta S, Dinh-Xuan AT, Duarte R, Evans CA, Garcia Calleja JM, GÃ¼nther G, Hoddinott G, Huddart S, Ivanova O, Laniado-LaborÃn R, Manga S, Manika K, Mariandyshev A, Mello FCQ, Mpagama SG, MuÃ±oz-Torrico M, Nahid P, Ong CWM, Palmero DJ, Piubello A, Pontali E, Silva DR, Singla R, Spanevello A, Tiberi S, Udwadia ZF, Vitacca M, Centis R, DÂ´Ambrosio L, Sotgiu G, Lange C, Visca D

The International Journal of Tuberculosis and Lung Disease

(2021)

https://doi.org/10.5588/ijtld.21.0425
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
van den Driessche K, Mahlobo PZ, Venter R, Caldwell J, Jennings K, Diacon AH, Cotton MF, de Groot R, Hens N, Marx FM, Warren RM, Mishra H, Theron GDV

The Lancet Respiratory Medicine

(2021)

https://doi.org/10.1016/s2213-2600(21)00020-5
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function
Allwood BW, Stolbrink M, Baines Na, Louw EH, Wademan DT, Lupton-Smith AR, Nel S, Maree DM, Mpagama S, Osman M, Marx FM, Hoddinott G, Lesosy M, Rylance J, Mortimer K

International Journal of Tuberculosis and Lung Disease

(2021)

https://doi.org/10.5588/ijtld.20.0906
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis
Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G

The Lancet Global Health

(2020)

https://doi.org/10.1016/S2214-109X(20)30227-8
Post-tuberculosis lung health: perspectives from the First International Symposium
Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, Evans CA, Evans D, Gray DM, Hoddinott G, Ivanova O, Jones R, Makanda G, Marx FM, Meghji J, Mpagama SG, Pasipanodya JG, Rachow A, Schoeman I, Shaw J, Stek C, van Kampen S, von Delft D, Walker NF, Wallis RS, Mortimer K

The International Journal of Tuberculosis and Lung Disease

(2020)

https://doi.org/10.5588/ijtld.20.0067
Inference of naturally-acquired immunity using a self-matched negative control design
Graham RN, Qian L, Bruxvoort K, Marx FM, Whittles LK, Lewnard J

Epidemiology

(2020)

https://doi.org/10.1097/EDE.0000000000001305
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
Mishra H, Reeve BWP, Palmer Z, Caldwell J, Dolby T, Naidoo CC, Jackson GJ, Schumacher SG, Denkinger CM, Diacon AH, van Helden PD, Marx FM, Warren RM, Theron G

The Lancet Respiratory Medicine

(2020)

https://doi.org/10.1016/S2213-2600(19)30370-4
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic
Quaife M, Houben RMJ, Allwood BW, Cohen T, Coussens AK, Harries AD, Marx FM, Sweeney S, Wallis RS, Menzies NA

The Lancet Respiratory Medicine

(2020)

https://doi.org/10.1016/S2213-2600(20)30039-4
Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa
Marx FM, Cohen T, Lombard C, Hesseling AC, Dlamini SS, Beyers N, Naidoo P

The International Journal of Tuberculosis and Lung Disease

(2019)

https://doi.org/10.5588/ijtld.18.0609
Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting
Dippenaar A, De Vos M, Marx FM, Adroub SA, van Helden PD, Pain A, Sampson SL, Warren RM

Infection, Genetics and Evolution

(2019)

https://doi.org/10.1016/j.meegid.2019.103948
Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study
Osman M, Welte A, Dunbar R, Brown R, Hoddinott G, Hesseling AC, Marx FM

International Journal of Infectious Diseases

(2019)

https://doi.org/10.1016/j.ijid.2019.05.024
The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study
Marx FM, Dunbar R, Enarson DA, Williams BG, Warren RM, van der Spuy G, van Helden PD, Beyers N

Clinical Infectious Diseases

(2014)

https://doi.org/10.1093/cid/ciu186
Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa
Osman M, Meehan S, Von Delft A, Du Preez K, Dunbar R, Marx FM, Boulle A, Welte A, Naidoo P, Hesseling AC

PLOS ONE

(2021)

https://doi.org/10.1371/Journal.pone.0252084

Marx FM

Sputum availability and quality in country-level TB prevalence surveys

Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research

Impact of interventions for tuberculosis prevention and care in South Africa – a systematic review of mathematical modelling studies

A systematic review of risk factors for mortality among tuberculosis patients in South Africa

Breathing back better! A state of the art on the benefits of functional evaluation and rehabilitation of post-tuberculosis and post-COVID lungs.

Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence?

Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care

Spatially targeted digital chest radiography to reduce tuberculosis in high-burden settings: a study of adaptive decision making

Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?

Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function

Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis

Post-tuberculosis lung health: perspectives from the First International Symposium

Inference of naturally-acquired immunity using a self-matched negative control design

Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study

Post-tuberculosis mortality and morbidity: valuing the hidden epidemic

Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa

Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting

Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study

The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study

Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa

Type

Year

Author